ESMO: European Society for Medical Oncology

1. Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reported for Multiple Cancers at ESMO Congress 2021 [ESMO Congress 2021 Press Release]

   Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

2. Vax-On Points to Maintenance of Active Anticancer Treatment Throughout the Whole COVID-19 Vaccination Schedule

   Findings from the Vax-On study show a favourable safety profile of mRNA-based COVID-19 vaccine in patients with solid tumours during active anticancer treatment

3. FDA Grants Accelerated Approval to Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer

   Evidence for efficacy is based on the results from the innovaTV 204 study

4. Addition of an EGFR Antibody to Fluorouracil/Folinic Acid Maintenance Therapy in RAS Wild-Type mCRC

   Findings from the PANAMA study (AIO KRK 0212)

5. A Novel Combination of Cabozantinib Plus Atezolizumab Demonstrates Encouraging Activity and Acceptable Tolerability in Advanced RCC

   Findings from the COSMIC-021 study